Hinge Bio
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE Systemic Lupus Erthematosus (SLE), Lupus Nephritis (LN), Extra-renal Lupus (ERL) | Phase 1 | 2026-03-23 |
| Recruiting | Single Ascending Dose Study of HB2198 in Healthy Participants Healthy Volunteer | Phase 1 | 2026-03-19 |